NCT07029100View on ClinicalTrials.gov

Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors.

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2029

Conditions
Glioblastoma
Interventions
OTHER

Ex-vivo organoid culture

ex-vivo organoid cultures composed of tumor cells within their microenvironment (glioblastoma organoid - GBO) and intra- and peri-tumoral blood vessels (blood vessel organoid - BVO), derived from perioperative samples obtained during complete or partial surgical resection

Trial Locations (3)

Unknown

Groupe Hospitalier du Havre, Le Havre

Centre Henri Becquerel, Rouen

CHU Rouen, Rouen

All Listed Sponsors
lead

Centre Henri Becquerel

OTHER

NCT07029100 - Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors. | Biotech Hunter | Biotech Hunter